ATRIUM MEDICAL CORPORATION – Trademark Portfolio
Entity Type: 03
ATRIUM MEDICAL CORPORATION holds 92 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 77 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include V12, C-QUR, ICAST, OASIS, and OCEAN. The owner is based in AMHERST, NH.
10 NORTHERN BOULEVARD
AMHERST, NH 03031
Showing of trademarks Trademarks
Trademark Classifications
ATRIUM MEDICAL CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ATRIUM MEDICAL CORPORATION have?
ATRIUM MEDICAL CORPORATION has 92 U.S. trademarks filed with the USPTO. Of these, 12 registered, 51 abandoned, 29 cancelled.
What trademark classes does ATRIUM MEDICAL CORPORATION file in?
ATRIUM MEDICAL CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 2 (Paints). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ATRIUM MEDICAL CORPORATION's most well-known trademarks?
ATRIUM MEDICAL CORPORATION's registered trademark portfolio includes well-known marks such as V12, C-QUR, ICAST, OASIS, and OCEAN. These are among 12 currently registered trademarks in the portfolio.
What is ATRIUM MEDICAL CORPORATION's trademark registration success rate?
ATRIUM MEDICAL CORPORATION has a 13% trademark registration rate, with 12 out of 92 resolved applications resulting in successful registration. Currently, 0 applications are pending review.